SCHEMBL2916635

SCHEMBL2916635

COc1cc(CCCO)cc(C2(C)CCCCC2)c1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 2/20 0.58
GAA P10253 1/20 0.40
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.39
ALOX12 P18054 1/20 0.39
RARA P10276 2/20 0.38
RARB P10826 2/20 0.38
RARG P13631 2/20 0.38
CNR2 P34972 4/20 0.38
AKR1B1 P15121 1/20 0.38
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35
TUBB3 Q13509 1/20 0.35
TUBB2A Q13885 1/20 0.35
TUBB8 Q3ZCM7 1/20 0.35
TUBA3E Q6PEY2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3155024 0.86 GAA (0.41) TNKS2GAAGLATSHRALOX12
SCHEMBL6567017 0.83 RARA (0.46) TNKS2TSHRRARARARBRARG
SCHEMBL2911296 0.82 GLA (0.44) TNKS2GAAGLATSHRALOX12
SCHEMBL13899762 0.81 GLA (0.46) TNKS2GAAGLATSHRALOX12
SCHEMBL2916191 0.80 GLA (0.45) TNKS2GAAGLATSHRALOX12
SCHEMBL13899797 0.80 GLA (0.39) TNKS2GAAGLATSHRALOX12
SCHEMBL14003069 0.80 GLA (0.44) TNKS2GAAGLATSHRALOX12
SCHEMBL7944933 0.79 TNKS2 (0.38) TNKS2GLATSHRALOX12RARA
SCHEMBL2908677 0.79 ALDH1A1 (0.40) TNKS2GAAGLATSHRALOX12
SCHEMBL2914283 0.78 TNKS2 (0.86) TNKS2GAAAKR1B1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2110370-B1 Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL CO (JP) 2010-09-01 EP disclosed
EP-2110370-A1 Method of producing p-hydroxyphenylalkanols Sumitomo Chemical Company, Limited (JP) 2009-10-21 EP disclosed
US-6717020-B2 HIGH YIELD REACTION OF PHENOLS AND UNSATURATED ALCOHOLS IN PRESENCE OF SUCH AS TITANIUM TETRAETHOXIDE AND SODIUM METHOXIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-04-06 US disclosed
US-20030195379-A1 Method of producing p-Hydroxyphenylalkanols SUMITOMO CHEMICAL COMPANY, LIMITED 2003-10-16 US disclosed
EP-1348686-A1 Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195379-A1 Method of producing p-Hydroxyphenylalkanols ADH1C, NR1H3, ADH5 TNKS2 3493/4885GAA 4341/4885GLA 2173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.